As of March 31, 2025, the Company’s cash, cash equivalents and investments was $314.2 million. The Company expects that its cash, cash equivalents and investments, as of March 31, 2025, will fund its ...

Lupus, an autoimmune disease affecting at least 5 million people worldwide and disproportionately impacting women, presents daily challenges for 30 to 50 out of every 100,000 individuals in the ...

and a carefully tailored diet for effective management. How lupus has affected Purity Nkatha's life Despite reaching out on ...

Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Greetings, and welcome to Exagen Inc. First Quarter 2025 Earnings ...

In honour of Lupus Awareness Month, Dr Deepthi Raju Abraham shares her inspiring journey with lupus, offering hope and ...

Comprehensive overview of lupus in India, symptoms, treatment, and challenges faced in diagnosis and management.

Medical alert systems make accessing help in ... activity tracking, and account management. Medication reminders, wellness checks, spouse monitoring, and activity tracking are some of the most ...

As a novel calcineurin inhibitor with proven efficacy in improving renal outcomes, LUPKYNIS addresses a high unmet medical need. With increasing awareness, supportive guidelines, and potential ...